Fred Hutchinson Cancer Center: clinical-trial pipeline
Fred Hutchinson Cancer Center is the sponsor of 544 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 96 are not yet finished and 4 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 179 |
| Phase 2 | 170 |
| Phase 1 | 81 |
| Phase 1/2 | 77 |
| Phase 3 | 23 |
| Phase 4 | 8 |
| Phase 2/3 | 5 |
| Early phase 1 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 351 |
| Terminated | 69 |
| Recruiting | 65 |
| Withdrawn or not authorised | 22 |
| Active, not recruiting | 17 |
| Not yet recruiting | 14 |
| Suspended or halted | 3 |
| Unknown | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 431 |
| Rare and genetic diseases | 112 |
| Haematology | 65 |
| Infectious disease and vaccines | 49 |
| Women's health and obstetrics | 32 |
| Nephrology and urology | 27 |
| Metabolic and endocrine (diabetes, obesity) | 22 |
| Dermatology | 19 |
| Gastroenterology and liver | 19 |
| Cardiovascular | 18 |
| Immunology and rheumatology | 18 |
| Respiratory | 16 |
Countries
| Country | Trials |
|---|---|
| United States | 518 |
| Italy | 16 |
| Germany | 13 |
| Peru | 5 |
| Denmark | 4 |
| Kenya | 4 |
| Uganda | 4 |
| Brazil | 3 |
| Zimbabwe | 2 |
| Canada | 1 |
| Switzerland | 1 |
| Cameroon | 1 |
| Dominican Republic | 1 |
| France | 1 |
| United Kingdom | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Tacabrutideg and Sonrotoclax, With Response-Guided Obinutuzumab, for the Treatment of Chr… |
| 2026-10-06 | New trial posted | Testing Pasritamig Before Surgery for the Treatment of Localized Prostate Cancer |
| 2026-09-14 | New trial posted | Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Diseas… |
| 2026-09-04 | New trial posted | IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Pro… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT00637689 | Improving Outcomes Assessment in Chronic GVHD | Not applicable | Active, not recruiting | United States |
| NCT07194980 | Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leuke… | Phase 2 | Recruiting | United States |
| NCT07490860 | A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Ind… | Not applicable | Recruiting | United States |
| NCT07011810 | Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Phase 2 | Recruiting | United States |
| NCT04083183 | Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant… | Phase 1/2 | Recruiting | United States |
| NCT07737314 | Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study | Not applicable | Not yet recruiting | United States |
| NCT06922188 | Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia | Not applicable | Recruiting | United States |
| NCT07615764 | An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among Amer… | Not applicable | Recruiting | United States |
| NCT07645352 | Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Wome… | Not applicable | Recruiting | Zimbabwe |
| NCT04254133 | Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study | Not applicable | Recruiting | United States |
| NCT05250037 | The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopo… | Not applicable | Active, not recruiting | United States |
| NCT04375631 | CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatme… | Phase 1 | Recruiting | United States |
| NCT03128034 | 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia,… | Phase 1/2 | Recruiting | United States |
| NCT06983899 | Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-… | Not applicable | Recruiting | United States |
| NCT05996627 | Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease | Phase 2 | Recruiting | United States |
| NCT07667335 | Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Me… | Phase 1/2 | Recruiting | United States |
| NCT07576725 | Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial | Phase 2 | Not yet recruiting | Uganda |
| NCT07561658 | TelePharm PrEP/PEP | Not applicable | Not yet recruiting | Kenya |
| NCT07535008 | Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease | Not applicable | Recruiting | United States |
| NCT06236139 | Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resista… | Phase 1/2 | Recruiting | United States |
| NCT05075759 | Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors… | Not applicable | Active, not recruiting | United States |
| NCT07466498 | Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Pr… | Phase 2 | Recruiting | United States |
| NCT06928662 | Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell… | Phase 1/2 | Recruiting | United States |
| NCT06298734 | High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial | Not applicable | Recruiting | United States |
| NCT07860255 | Testing Pasritamig Before Surgery for the Treatment of Localized Prostate Cancer | Phase 1 | Not yet recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Fred Hutchinson Cancer Center clinical trials: 96 open, 28 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/fred-hutchinson-cancer-center/, data as of 2026-10-25.